Your browser doesn't support javascript.
loading
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study.
Stefanakis, Konstantinos; Kokkinos, Alexander; Argyrakopoulou, Georgia; Konstantinidou, Sofia K; Simati, Stamatia; Kouvari, Matina; Kumar, Ajay; Kalra, Bhanu; Kumar, Melina; Bontozoglou, Nikolaos; Kyriakopoulou, Konstantina; Mantzoros, Christos S.
Afiliação
  • Stefanakis K; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Boston VA Healthcare System and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Kokkinos A; First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Argyrakopoulou G; First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Konstantinidou SK; Diabetes and Obesity Unit, Athens Medical Center, Athens, Greece.
  • Simati S; First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Kouvari M; Diabetes and Obesity Unit, Athens Medical Center, Athens, Greece.
  • Kumar A; First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Kalra B; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Boston VA Healthcare System and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Kumar M; Ansh Labs, Webster, Texas, USA.
  • Bontozoglou N; Ansh Labs, Webster, Texas, USA.
  • Kyriakopoulou K; Ansh Labs, Webster, Texas, USA.
  • Mantzoros CS; Department of Radiology, Athens Medical Center, Athens, Greece.
Diabetes Obes Metab ; 25(9): 2561-2574, 2023 09.
Article em En | MEDLINE | ID: mdl-37246799

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article